Search
Sponsor

AIDS study hopes to build on trial’s success

For the first time ever, an AIDS vaccine has protected subjects of a clinical trial from infection. Now directors of a new Seattle-based study are hoping for a repeat performance — or maybe even a cure.

Related posts:

  1. Teen slackers study mom, not their school work
  2. AIDS, other STDs rising among local gay men
  3. Study: Popular drug for breast cancer saves lives but has risks

Leave a Reply

You must be logged in to post a comment.

Categories
Sponsor
Finance Infos